Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
245 studies found for:    "Gallbladder Diseases"
Show Display Options
Rank Status Study
21 Recruiting Laparoscopy-assisted ERCP in Patients With Altered Gastric Anatome
Conditions: Biliary Disease;   Pancreas Disease
Intervention: Procedure: Laparoscopy assisted ERCP
22 Recruiting Los Angeles Prospective GI Biliary and EUS Series
Conditions: Biliary Disease;   Pancreatitis;   Gastrointestinal Neoplasms
Intervention: Other: clinical course
23 Completed Single-operator Wire-guided Endoscopic Retrograde Cholangiopancreatography Cannulation Technique
Conditions: Biliary Diseases;   Pancreas Diseases
Interventions: Procedure: Team 1;   Procedure: Team 2
24 Recruiting EUS-Guided Rendezvous or Direct Interventions Versus Advanced ERCP Techniques for Biliary Access and Therapy
Conditions: Disorders of Gallbladder;   Disorders of Biliary Tract
Interventions: Procedure: EUS-Rendezvous or direct intervention;   Procedure: Advanced ERCP Biliary Access Techniques
25 Completed Cocktail Sedation Containing Propofol Versus Conventional Sedation for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Condition: Disorders of Gallbladder, Biliary Tract and Pancreas
Intervention: Drug: propofol
26 Completed
Has Results
Efficacy and Safety Profiles of Combination Sedation Propofol With Midazolam and Meperidine.
Condition: Disorders of Gallbladder, Biliary Tract and Pancrease
Interventions: Drug: Propofol;   Drug: Midazolam;   Drug: Meperidine
27 Unknown  Transient ECG Changes in Patients With Acute Biliary Disease
Conditions: Acute Cholecystitis;   Biliary Colic;   Acute Cholangitis
Intervention:
28 Completed Prospective Trial for Endoscopic Ultrasound Guided Gallbladder Drainage for Acute Cholecystitis in High Risk Patients
Condition: Cholecystitis
Interventions: Procedure: EUS-guided gallbladder drainage;   Procedure: percutaneous transhepatic gallbladder drainage
29 Recruiting Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
Conditions: Adult Cholangiocarcinoma;   Advanced Adult Hepatocellular Carcinoma;   BCLC Stage C Adult Hepatocellular Carcinoma;   BCLC Stage D Adult Hepatocellular Carcinoma;   Hilar Cholangiocarcinoma;   Localized Non-Resectable Adult Liver Carcinoma;   Recurrent Adult Liver Carcinoma;   Recurrent Childhood Liver Cancer;   Recurrent Extrahepatic Bile Duct Carcinoma;   Recurrent Gallbladder Carcinoma;   Stage II Gallbladder Cancer;   Stage III Childhood Hepatocellular Carcinoma;   Stage IIIA Gallbladder Cancer;   Stage IIIB Gallbladder Cancer;   Stage IV Childhood Hepatocellular Carcinoma;   Stage IV Distal Bile Duct Cancer;   Stage IVA Gallbladder Cancer;   Stage IVB Gallbladder Cancer;   Unresectable Extrahepatic Bile Duct Carcinoma
Interventions: Drug: Trametinib;   Drug: Leucovorin Calcium;   Drug: Fluorouracil;   Drug: Capecitabine;   Other: Laboratory Biomarker Analysis
30 Completed Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy
Conditions: Uncomplicated Cholelithiasis;   Cholecystectomy;   Laparoscopy;   Standard Technique;   Single Port Laparoscopy
Interventions: Other: Laparoscopic cholecystectomy;   Other: Single incision laparoscopic cholecystectomy
31 Unknown  Single Port Access (SPA) Cholecystectomy Versus Standard Laparoscopic Cholecystectomy
Conditions: Symptomatic Gallbladder Stones;   Cholecystitis;   Biliary Pancreatitis
Interventions: Procedure: SPA cholecystectomy;   Procedure: Laparoscopic cholecystectomy
32 Completed Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions: Drug: gemcitabine hydrochloride;   Drug: pemetrexed disodium
33 Unknown  Minilaparoscopic Versus Conventional Laparoscopic Cholecystectomy
Conditions: Cholelithiasis;   Cholecystectomy
Interventions: Procedure: Laparoscopic cholecystectomy;   Procedure: Minilaparoscopic cholecystectomy
34 Completed Palliative Biliary Stenting on the Quality of Life of Patients With Unresectable Carcinoma Gallbladder With Hiliar Block.
Condition: Gallbladder Cancer
Intervention: Procedure: Biliary stenting
35 Completed UDCA for Symptomatic Gallstone Disease
Condition: Cholecystolithiasis
Intervention: Drug: ursodeoxycholic acid
36 Not yet recruiting Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial
Conditions: Post-operative Pain;   Gallstone Disease
Interventions: Device: CTB group;   Device: PCIA group
37 Completed Indications for Gallbladder Surgery in Gallstone Disease
Condition: Gallstones
Intervention: Procedure: Cholecystectomy operation
38 Completed Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Conditions: Adenocarcinoma of the Colon;   Adenocarcinoma of the Gallbladder;   Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Rectum;   Adult Primary Hepatocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Gallbladder;   Diffuse Adenocarcinoma of the Stomach;   Intestinal Adenocarcinoma of the Stomach;   Male Breast Cancer;   Mixed Adenocarcinoma of the Stomach;   Ovarian Endometrioid Adenocarcinoma;   Paget Disease of the Breast With Intraductal Carcinoma;   Paget Disease of the Breast With Invasive Ductal Carcinoma;   Recurrent Adult Primary Liver Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Gallbladder Cancer;   Recurrent Gastric Cancer;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Pancreatic Cancer;   Recurrent Rectal Cancer;   Recurrent Salivary Gland Cancer;   Salivary Gland Adenocarcinoma;   Stage II Malignant Testicular Germ Cell Tumor;   Stage II Pancreatic Cancer;   Stage III Colon Cancer;   Stage III Gastric Cancer;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Pancreatic Cancer;   Stage III Rectal Cancer;   Stage III Salivary Gland Cancer;   Stage IIIA Breast Cancer;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Gastric Cancer;   Stage IV Pancreatic Cancer;   Stage IV Rectal Cancer;   Stage IV Salivary Gland Cancer;   Thyroid Gland Medullary Carcinoma;   Unresectable Gallbladder Cancer
Interventions: Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine;   Biological: sargramostim;   Biological: recombinant fowlpox GM-CSF vaccine adjuvant
39 Unknown  Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Liver Cancer;   Nausea and Vomiting;   Pancreatic Cancer;   Primary Peritoneal Cavity Cancer;   Small Intestine Cancer
Interventions: Drug: palonosetron hydrochloride;   Other: placebo
40 Unknown  Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
Conditions: Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Liver Cancer
Interventions: Biological: filgrastim;   Drug: pegylated liposomal doxorubicin hydrochloride

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years